mebendazole has been researched along with Birth Weight in 3 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
Birth Weight: The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The Israeli Teratogen Information Service prospectively collected and followed 192 pregnancies exposed to mebendazole in pregnancy, 71." | 7.72 | Pregnancy outcome after gestational exposure to mebendazole: a prospective controlled cohort study. ( Arnon, J; Diav-Citrin, O; Lubart, I; Ornoy, A; Shechtman, S, 2003) |
| "664) was found between the mebendazole group and the placebo group in terms of numbers of miscarriages, malformations, stillbirths, early neonatal deaths and premature babies (28 versus 31, respectively)." | 5.12 | Lack of risk of adverse birth outcomes after deworming in pregnant women. ( Casapia, M; Gotuzzo, E; Gyorkos, TW; Larocque, R, 2006) |
| "The objectives of the study was to check the embryotoxic-teratogenic and fetotoxic effect of mebendazole (Vermox; Richter, Budapest, Hungary) treatment during pregnancy." | 3.73 | Population-based case-control study of mebendazole in pregnant women for birth outcomes. ( Acs, N; Bánhidy, F; Czeizel, AE; Puhó, E, 2005) |
| "The Israeli Teratogen Information Service prospectively collected and followed 192 pregnancies exposed to mebendazole in pregnancy, 71." | 3.72 | Pregnancy outcome after gestational exposure to mebendazole: a prospective controlled cohort study. ( Arnon, J; Diav-Citrin, O; Lubart, I; Ornoy, A; Shechtman, S, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diav-Citrin, O | 1 |
| Shechtman, S | 1 |
| Arnon, J | 1 |
| Lubart, I | 1 |
| Ornoy, A | 1 |
| Acs, N | 1 |
| Bánhidy, F | 1 |
| Puhó, E | 1 |
| Czeizel, AE | 1 |
| Gyorkos, TW | 1 |
| Larocque, R | 1 |
| Casapia, M | 1 |
| Gotuzzo, E | 1 |
1 trial available for mebendazole and Birth Weight
| Article | Year |
|---|---|
Lack of risk of adverse birth outcomes after deworming in pregnant women.
Topics: Animals; Antinematodal Agents; Birth Weight; Double-Blind Method; Endemic Diseases; Female; Hookworm | 2006 |
2 other studies available for mebendazole and Birth Weight
| Article | Year |
|---|---|
Pregnancy outcome after gestational exposure to mebendazole: a prospective controlled cohort study.
Topics: Abnormalities, Drug-Induced; Abortion, Induced; Adult; Antinematodal Agents; Birth Weight; Cohort St | 2003 |
Population-based case-control study of mebendazole in pregnant women for birth outcomes.
Topics: Abnormalities, Drug-Induced; Birth Weight; Case-Control Studies; Female; Gestational Age; Humans; In | 2005 |